Health Care & Life Sciences » Pharmaceuticals | FluoroPharma Medical Inc.

FluoroPharma Medical Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Cost of Goods Sold (COGS) incl. D&A
24.50
24.50
42.50
46.40
43.90
Gross Income
24.50
24.50
42.50
46.40
43.90
SG&A Expense
3,991.10
4,209.40
5,126.40
3,140.00
2,158.50
EBIT
4,015.50
4,233.90
5,168.80
-
2,202.40
Unusual Expense
0.90
574.50
1,456.20
723.90
1,304.60
Non Operating Income/Expense
1.10
747.80
313.70
172.10
109.90
Interest Expense
-
51.40
104.10
873.40
1,262.00
Pretax Income
4,016.70
5,607.30
4,130.50
3,163.70
2,049.90
Consolidated Net Income
4,016.70
5,607.30
4,130.50
3,163.70
2,049.90
Net Income
4,016.70
5,607.30
4,130.50
3,163.70
2,049.90
Net Income After Extraordinaries
4,016.70
5,607.30
4,130.50
3,163.70
2,049.90
Net Income Available to Common
4,184.70
7,284.10
4,692.10
3,737.70
2,573.30
EPS (Basic)
0.18
0.30
0.16
0.12
0.08
Basic Shares Outstanding
22,642.80
24,374.00
28,641.20
30,038.20
33,556.20
EPS (Diluted)
0.18
0.30
0.16
0.12
0.08
Diluted Shares Outstanding
22,642.80
24,374.00
28,641.20
30,038.20
33,556.20
EBITDA
3,991.10
4,209.40
5,126.40
3,140.00
2,158.50
Non-Operating Interest Income
0.80
0.20
0.00
-
-
Preferred Dividends
167.90
1,676.80
561.50
574.00
523.40

About FluoroPharma Medical

View Profile
Address
8 Hillside Avenue
Montclair New Jersey 07042
United States
Employees -
Website http://www.fluoropharma.com
Updated 07/08/2019
FluoroPharma Medical, Inc. engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.